Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). - sprookjes - yvandenbroek - TriplyDB

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

http://www.wikidata.org/entity/Q34586454

about

Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease Angioplasty versus stenting for iliac artery lesions Angioplasty versus bare metal stenting for superficial femoral artery lesions Screening for peripheral arterial disease Propionyl-L-carnitine for intermittent claudication Disease management interventions for improving self-management in lower-limb peripheral arterial disease Naftidrofuryl for intermittent claudication Screening for peripheral arterial disease Antiplatelet agents for intermittent claudication Angioplasty versus stenting for superficial femoral artery lesions Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery Naftidrofuryl for intermittent claudication Management of lower extremity peripheral arterial disease Retrospective angiographic study to determine the effect of atherosclerotic stenoses of upstream arteries on the degree of atherosclerosis in distal vascular territories The Completeness of Intervention Descriptions in Randomised Trials of Supervised Exercise Training in Peripheral Arterial Disease Comparing Supervised Exercise Therapy to Invasive Measures in the Management of Symptomatic Peripheral Arterial Disease Cell Therapy in Patients with Critical Limb Ischemia Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis Korean Guidelines for Interventional Recanalization of Lower Extremity Arteries Peripheral artery disease and non-coronary atherosclerosis in Hispanics: another paradox?Critical limb ischemia: advanced medical therapy The role of atherectomy in the treatment of lower extremity peripheral artery disease Imaging of small animal peripheral artery disease models: recent advancements and translational potential Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients.2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Gu Pulsed high-intensity-focused US and tissue plasminogen activator (TPA) versus TPA alone for thrombolysis of occluded bypass graft in swine.K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model Peripheral artery disease: epidemiology and global perspectives.Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.Serum Thyrotropin Concentrations Are Not Associated with the Ankle-Brachial Index: Results from Three Population-Based Studies Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.Peripheral arterial disease in diabetes: is there a role for genetics?Multimodality image fusion to guide peripheral artery chronic total arterial occlusion recanalization in a swine carotid artery occlusion model: unblinding the interventionalist Data on amputation free survival of patients with lower limb peripheral artery disease classified according TASC II classification and a new crural index.Role of infrainguinal angioplasty in the treatment of critical limb ischaemia.Current state of endovascular treatment of femoro-popliteal artery disease.

P2860

Q24186303-53D544EF-34D5-416D-87FE-F6D1219E762C Q24187772-77DB235E-C8AA-4918-8091-4C0B56CB6BB2 Q24193807-C78315BB-F91B-4758-A79E-98FE65690132 Q24197484-56F32652-F059-44AE-9647-D0B6B08755DC Q24201080-E196DDD5-9ED8-4471-89B5-F8ED70F55534 Q24201570-0D5FB762-71DB-44DA-BB2B-6A43CDA0D1B4 Q24202499-6F533645-AA4E-432B-9D04-F9DAE70A35C8 Q24202715-6880BD8F-0D99-47AE-878D-64932F74F73E Q24235178-AB7EBE35-B3D6-4CA9-9643-37E1C75090A9 Q24241014-F9B00D60-4C62-488F-BF4E-C4EED644715B Q24242603-C6879D52-5A3A-4626-A91F-D955EABD2DC1 Q24242960-2B14DB30-1967-45D9-9A8C-88CF9F3509D4 Q24655017-77B9B4DA-6D09-4C1E-A0E3-667F37D95CB8 Q24658531-7818AA0D-625B-411F-B3F3-B990EA02553B Q26764726-018731CC-52F9-4704-A0B1-F7605F36AC7E Q26776109-7B0462C2-66E7-40B3-BAEA-A752C444F6AC Q26795443-B1C1BBC1-78EF-4120-A25D-E20A291EC984 Q26798134-C1062390-039F-40E9-99D7-3EBFF8A0B89D Q26801709-9FB93A1F-7453-4E5F-926C-03ECF4F8CF80 Q26828001-3047B6BF-5284-4557-8264-EF172BDF0941 Q26995245-3029132B-8DC9-40ED-A852-E01B15C84567 Q27002637-1B80AB89-3323-40C9-9A27-A986F75C069D Q27009178-732FA214-FB7E-40CD-81F4-68AD547B9314 Q27010236-80F034F8-F9DF-4B11-86C6-8E963FE65969 Q27303621-D20A4A73-EC7A-48D6-BB06-9CF32C75E8F4 Q28249469-E479966B-7692-434E-A695-8717FD5822D9 Q28267010-9B298C5B-790F-4CCE-A6E5-FAB493EF9948 Q28484521-323432CD-57BC-40C5-96D9-DC8D795D8129 Q30241154-F17E038C-6D1A-4A50-A090-B8F387B0D0FD Q30278668-A8BAB0D0-DC22-4FC8-A419-6C6D79E14122 Q30300196-2CA3274A-DC54-4859-8F66-4FBC1FD27F4D Q30313782-71498A5E-290D-44A5-97DB-769332F6811B Q30315945-9A6F2146-AC4B-489A-A2AE-DCD656B7716E Q30354271-81BC990D-E9E6-42F5-80F1-25AF9F14305D Q30414524-F5A5F154-108A-4D6E-B5A8-091AD895BBF6 Q30426617-65314E26-6D05-4BAB-80F7-507E6DC28649 Q30446503-E249F330-674D-4DE3-A2EC-43F76F14AC41 Q31109821-3FA07B35-23B3-46D1-84CA-CBF9707532CF Q33282882-FD67EF1C-E98B-402B-9269-D985337A52E8 Q33298566-72FC6267-A193-462D-84E4-30310F632DB2

P2860

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

http://www.wikidata.org/entity/Q34586454

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@ast

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@en

Inter-Society Consensus for the Management of Peripheral Arterial Disease

@nl

type

label

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@ast

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@en

Inter-Society Consensus for the Management of Peripheral Arterial Disease

@nl

prefLabel

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@ast

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@en

Inter-Society Consensus for the Management of Peripheral Arterial Disease

@nl

P1433

Q34586454-3BA1A411-41CB-40C8-8E73-180DE72F3528

P1476

Q34586454-B30A9DAB-9084-4F2A-B758-B044FDEDD846

P2093

Q34586454-174B2039-4CA2-4741-A48D-5800F3BC3A5A

Q34586454-181136D4-6226-4AA0-BDAD-E6E3D839E1F2

Q34586454-1978887D-39B8-47D6-8FBB-60E972D8E871

Q34586454-1FA66BA6-FF48-4268-B68F-8E312F6572D9

Q34586454-251F7A1B-A67F-4C35-95FC-BCC04DEBEB42

Q34586454-29EECFA2-37A8-469E-896C-FCEE255193A7

Q34586454-30E937E8-9C3A-4F0A-A6D3-531FD84B8574

Q34586454-341C9FB8-8D66-495E-A8F2-518EE6010B24

Q34586454-3EF2543C-E8BC-4135-909A-8C2A75A9D7DD

Q34586454-445CAFA1-AD93-4AE5-8FE6-D300B368E9F0

P304

Q34586454-066EA4E3-2DB5-43C0-AE73-8D75075EAD70

P31

Q34586454-0866F1DB-54E6-4851-B2B6-C65F963EA4F5

P356

Q34586454-A307DD63-28E9-4282-9455-8DA34AE0992D

P478

Q34586454-256431DD-0B08-4FFA-8F80-293EBAD5EC05

P50

Q34586454-02592EBE-7ADE-49B1-9057-B3532323504F

P577

Q34586454-7970D9AB-F8C6-4CFA-8041-92397ACC0D71

P5875

Q34586454-11484B38-6D94-4B66-9720-57FFB91A3F66

P698

Q34586454-C080F8E6-58E8-4F8B-A7B7-0BAE91C916FB

P356

J.EJVS.2006.09.024

P1433

European Journal of Vascular and Endovascular Surgery

P1476

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

@en

P2093

Christopher White

http://www.w3.org/2001/XMLSchema#string

Christos Liapis

http://www.w3.org/2001/XMLSchema#string

Denis Clement

http://www.w3.org/2001/XMLSchema#string

Emile Mohler

http://www.w3.org/2001/XMLSchema#string

F G R Fowkes

http://www.w3.org/2001/XMLSchema#string

Henrik Sillesen

http://www.w3.org/2001/XMLSchema#string

Hiroshi Shigematsu

http://www.w3.org/2001/XMLSchema#string

Isabelle Durand-Zaleski

http://www.w3.org/2001/XMLSchema#string

J A Dormandy

http://www.w3.org/2001/XMLSchema#string

Johannes Lammer

http://www.w3.org/2001/XMLSchema#string

P304

S1-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJVS.2006.09.024

http://www.w3.org/2001/XMLSchema#string

P478

33 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Durand-Zaleski

P577

2006-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6657827

http://www.w3.org/2001/XMLSchema#string

P698

17140820

http://www.w3.org/2001/XMLSchema#string